Lab21, IntegraGen Co-developing CDx for Colorectal Cancer Therapy
February 22, 2013
Lab21, IntegraGen Co-developing CDx for Colorectal Cancer Therapy
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Lab21, IntegraGen to Develop PCR-Based Assay to Guide Colorectal Cancer Therapy
February 28, 2013 / PCR Insider - Lab21 to Develop microRNA-Based Colorectal Cancer Diagnostic for IntegraGen
February 28, 2013 / Gene Silencing News - Qiagen, Eli Lilly Enter CDx Deal
February 14, 2013 / GenomeWeb Daily News - Qiagen, Bayer Partner on Cancer Companion Dx
October 25, 2012 / GenomeWeb Daily News - BD, Lab21 Team on Oncology Assays
October 15, 2012 / GenomeWeb Daily News